Edge-Enabled Hybrid Encryption Framework for Secure Health Information Exchange in IoT-Based Smart Healthcare Systems. [PDF]
Ghani NA +4 more
europepmc +1 more source
The Nonlinear Filter Model of Stream Cipher Redivivus [PDF]
Claude Carlet, Palash Sarkar
openalex +1 more source
Aggressive prostate cancer is associated with pericyte dysfunction
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero +11 more
wiley +1 more source
Bitwise XOR linear space creation through permutation and the ease to enable XOR-free processes. [PDF]
Shetty S +3 more
europepmc +1 more source
Exploring HPC and ML Techniques on Various Classical, Machine and Modern Ciphers [PDF]
Venu Nalla +3 more
openalex +1 more source
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang +8 more
wiley +1 more source
LWLCM: A novel lightweight stream cipher using logistic chaos function and multiplexer for IoT communications. [PDF]
Afzal S +5 more
europepmc +1 more source
Lifta: The Cipher of the Landscape - A Photographic Essay [PDF]
Rema Hammami, Rula Halawani
openalex +1 more source
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard +5 more
wiley +1 more source
Low burden of clinically relevant anaemia and thrombocytopenia among adolescents living with HIV receiving tenofovir/lamivudine plus dolutegravir: the CIPHER-ADOLA study in Cameroon. [PDF]
Fainguem NN +42 more
europepmc +1 more source

